Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XX Other antibacterials
J01XX12 Lefamulin
D11631 Lefamulin (USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01813 Pleuromutilin
DG03066 Lefamulin
D11631 Lefamulin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03066 Lefamulin
D11631 Lefamulin
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Pleuromutilin
D11631 Lefamulin (USAN/INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11631
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11631
Drug groups [BR:br08330]
Antibacterial
DG01813 Pleuromutilin
DG03066 Lefamulin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG03066 Lefamulin
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Pleuromutilin
DG03066 Lefamulin